Clinical Trials Browser

Completed × Pancreatic Ductal Adenocarcinoma × 90 days × Clear all

NCT03851237 2025-12-23

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Phase 1 Completed

Gastrointestinal

Pancreatic Ductal Adenocarcinoma